Literature DB >> 16517728

Molecular mechanisms underlying FOXP3 induction in human T cells.

Pierre-Yves Mantel1, Nadia Ouaked, Beate Rückert, Christian Karagiannidis, Roland Welz, Kurt Blaser, Carsten B Schmidt-Weber.   

Abstract

FOXP3 is playing an essential role for T regulatory cells and is involved in the molecular mechanisms controlling immune tolerance. Although the biological relevance of this transcription factor is well documented, the pathways responsible for its induction are still unclear. The current study reveals structure and function of the human FOXP3 promoter, revealing essential molecular mechanisms of its induction. The FOXP3 promoter was defined by RACE, cloned, and functionally analyzed using reporter-gene constructs in primary human T cells. The analysis revealed the basal, T cell-specific promoter with a TATA and CAAT box 6000 bp upstream the translation start site. The basal promoter contains six NF-AT and AP-1 binding sites, which are positively regulating the trans activation of the FOXP3 promoter after triggering of the TCR. The chromatin region containing the FOXP3 promoter was bound by NF-ATc2 under these conditions. Furthermore, FOXP3 expression was observed following TCR engagement. Promoter activity, mRNA, and protein expression of T cells were suppressed by addition of cyclosporin A. Taken together, this study reveals the structure of the human FOXP3 promoter and provides new insights in mechanisms of addressing T regulatory cell-inducing signals useful for promoting immune tolerance. Furthermore, the study identifies essential, positive regulators of the FOXP3 gene and highlights cyclosporin A as an inhibitor of FOXP3 expression contrasting other immunosuppressants such as steroids or rapamycin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517728     DOI: 10.4049/jimmunol.176.6.3593

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  144 in total

Review 1.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  Transcription start sites and usage of the first exon of mouse Foxp3 gene.

Authors:  Toshitsugu Fujita; Hodaka Fujii
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

Review 3.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

4.  PTPN22 alters the development of regulatory T cells in the thymus.

Authors:  Christian J Maine; Emma E Hamilton-Williams; Jocelyn Cheung; Stephanie M Stanford; Nunzio Bottini; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

Review 5.  The molecular mechanisms of Foxp3 gene regulation.

Authors:  Takashi Maruyama; Joanne E Konkel; Brian F Zamarron; WanJun Chen
Journal:  Semin Immunol       Date:  2011-07-12       Impact factor: 11.130

6.  Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I.

Authors:  Lili Xu; Atsushi Kitani; Christina Stuelten; George McGrady; Ivan Fuss; Warren Strober
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

Review 7.  Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.

Authors:  Robert Zeiser; Robert S Negrin
Journal:  Cell Cycle       Date:  2007-12-18       Impact factor: 4.534

8.  Diacylglycerol kinase ζ limits the generation of natural regulatory T cells.

Authors:  Amanda M Schmidt; Tao Zou; Rohan P Joshi; Theresa M Leichner; Matthew A Pimentel; Connie L Sommers; Taku Kambayashi
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

Review 9.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

10.  Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells.

Authors:  Zhuoxiao Cao; Akm Khyrul Wara; Basak Icli; Xinghui Sun; René R S Packard; Fehim Esen; Christopher J Stapleton; Malayannan Subramaniam; Karsten Kretschmer; Irina Apostolou; Harald von Boehmer; Göran K Hansson; Thomas C Spelsberg; Peter Libby; Mark W Feinberg
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.